- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05938621
Estamos Juntos (We Are Together): Improving HIV Care Delivery by Capacitating Health Care Providers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Mozambique has made progress towards their 95-95-95 goals, yet only 65% of people newly initiated in HIV treatment remain in care at 12 months. HIV treatment adherence has been undermined by a lack of compassionate health care service delivery. People living with HIV in our study region of Zambezia province report being treated disrespectfully by health care workers as one of the leading causes of treatment abandonment. Common complaints include insulting patients' intellectual capacity, ignoring concerns with side effects or co-occurring infections, and refusing to treat patients seen as "unworthy". While health care worker behavior is appalling, it is likely a reflection of high rates of burnout, job dissatisfaction, and frustration with patients they perceive to be uncooperative.
The implementation of Estamos Juntos (We are Together) will allow us to test a multiprong intervention designed to address provider-barriers to delivering compassionate care via two synergistic components: (1) Resilience and well-being training for health care providers who have expressed low job satisfaction, frustration with delivering care in an extremely resource-limited setting, and burnout; and (2) Anti-stigma training for health care providers who see those with low socioeconomic status, low levels of education, and those living with HIV as "lesser-than" themselves. We propose to pilot test the implementation and impact of each psychosocial intervention individually, and in combination, using a randomized controlled trial design at four health facilities. We hypothesize that the facility where health care workers receive both resilience and anti-stigma training will see the greatest change in health care worker outcomes, including decreased stigmatizing attitudes, emotional exhaustion, and depersonalize of their patients, as well as increased resilience and job satisfaction. Patients receiving care and treatment from intervention providers will show increased retention and medication adherence, as well as improvements in health care services satisfaction, medical mistrust, and perceived stigma from health care providers.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Carolyn M Audet, PhD
- Phone Number: 6153432418
- Email: carolyn.m.audet@vumc.org
Study Contact Backup
- Name: Erin Graves, MPH
- Email: erin.r.graves.1@vumc.org
Study Locations
-
-
Zambezia
-
Quelimane, Zambezia, Mozambique
- Recruiting
- Ministry of Health
-
Contact:
- Caroline DeSchacht, MD
- Phone Number: +258823393460
- Email: caroline.deschacht@fgh.org.mz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Provider Criteria
Inclusion Criteria:
- Adult individuals, 18 years of age or older;
- working as physicians, nurses, medical technicians, health counselors, community health care workers, or other clinical and non-clinical staff (e.g., receptionists, data entry clerk) who provide health services to adults living with HIV at one of the four study sites;
- willing to be followed as a study participant during the 6-month study period, and does not intend to transfer to another health facility (HF) during the study period (per investigator's assessment at time of recruitment), as self-reported.
- Be able to read and write in Portuguese, as self-reported.
Exclusion Criteria:
- Those who are not permanent members of the health facility staff (i.e., floating providers that work at multiple sites in a given week);
- Any clinical or mental condition, including the influence of drugs or alcohol at the time of study recruitment, that as per the investigator's opinion/assessment, would preclude the provision of informed consent or make study participation unsafe or unethical;
- Individuals working in the health facility but from the following cadres: drivers, security personnel, and workers with no patient-facing roles.
Patient Criteria
Inclusion:
- Adult individuals, 18 years of age or older
- Active in care (i.e., not in default)
- Receiving HIV care and treatment at one of the four study sites.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard of Care
Health care providers in this arm will receive no intervention
|
|
Experimental: Resilience intervention
Providers in this arm will receive training to improve their resilience and well-being
|
Sessions that focus on developing self-awareness and strategies to improve well-being will be the focus of the interventions.
|
Experimental: Resilience and Stigma group
Providers in this group will receive training to improve their resilience and well-being as well as receive sessions about the impact of stigmatizing their patients.
|
Sessions that focus on developing self-awareness and strategies to improve well-being will be the focus of the interventions.
|
Experimental: Anti-stigma group
Providers in this group will receive sessions focusing on the impact that stigmatizing patients can have on themselves and their patients.
Strategies to minimize negative feelings will be developed.
|
Sessions that focus on developing self-awareness and strategies to improve well-being will be the focus of the interventions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Burnout
Time Frame: 6 months
|
Burnout screening tool
|
6 months
|
Antiretroviral Therapy (ART) adherence
Time Frame: 12 months
|
Medication possession ratio
|
12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- R34MH127975 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hiv
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Hospital Clinic of BarcelonaCompletedIntegrase Inhibitors, HIV; HIV PROTEASE INHIBSpain
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
Clinical Trials on behavioral therapy and education
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer... and other conditionsUnited States
-
Brigham and Women's HospitalMassachusetts General Hospital; National Institute of Arthritis and Musculoskeletal...Completed
-
University of California, Los AngelesNational Institute on Aging (NIA)Completed
-
Roswell Park Cancer InstituteRecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
University of California, Los AngelesNational Institute of Nursing Research (NINR)Completed
-
University of FloridaNational Institutes of Health (NIH)Completed
-
Jiangsu Province Nanjing Brain HospitalEnrolling by invitationDepression | Stress | Insomnia | AnxietyChina
-
University of VermontNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedChronic PainUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingObesity-Related Malignant NeoplasmUnited States
-
University of WashingtonUniversity of North Carolina; MultiCare Mary Bridge Children's Hospital & Health...Completed